Citations

Showing 10 of 108094 citations.

Polygenic risk score analysis identifies deleterious protein-coding variants in novel immune pathway genes ATP8B4, FCGR1A, and LILRB1 that associate with Alzheimer’s disease.
Reddy, Joseph S. , Wang, Xue , Allen, Mariet , Carrasquillo, Minerva M. , Jenkins, Gregory D. , Belbin, Olivia , Golde, Todd E. , Ertekin‐Taner, Nilüfer , Younkin, Steven G. , Belbin, Olivia , Carrasquillo, Minerva M. , Biernacka, Joanna M. , Coombes, Brandon J.

Mayo Clinic

No container title available | August 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1885551/v1 Get It

Abstract Background: Alterations in innate immunity are pathologically associated with and genetically implicated in Alzheimer’s disease (AD). In the whole exome sequence (WES) dataset generated by the Alzheimer’s Disease Sequencing Project (ADSP), only the previously identified p.R47H variant in the innate immunity gene, TREM2, shows study-wide association with risk of AD. Using a novel approach, we searched the ADSP WES data to identify additional immune pathway genes with deleterious variants that, like TREM2.pR47H, show strong association with AD. Methods: Using polygenic risk scores (PRS) to analyze association with AD, we evaluated deleterious variants (CADD Phred-scaled score > 20) with a minor allele count of 20 or more in 228 genes comprising an immune co-expression network containing TREM2 (CENTREM2). A significant polygenic component composed of deleterious stop-gain and non-synonymous variants was identified, and false discovery rates were determined for the variants in this component. In genes harboring a significant variant, PRS for all variants in the genes were then analyzed. Results: The PRS for the 182 deleterious variants in CENTREM2 showed significant association with AD that was driven by 142 deleterious variants (136 non-synonymous, 6 stop-gain). In the 142 variant polygenic component, four variants had significant AD risk association: TREM2.pR47H, two deleterious stop-gain variants (FCGR1A.pR92X, and LILRB1.pY331X) in novel AD genes and 1 non-synonymous variant (ATP8B4.pG395S). Remarkably, PRS for the 36 additional variants in these four genes also showed significant association with AD. The PRS for all 40 variants in the 4 genes, showed significant, replicable association with AD and 3 additional variants in this polygenic component had significant false discovery rates: ATP8B4.pR1059Q, LILRB1.pP7P, and LILRB1.pY327Y. Conclusions: Here, we identify 3 immune pathway genes (ATP8B4, LILRB1, and FCGR1A) with a variant that associates with AD. Like TREM2.pR47H, each of the variants has a minor allele frequency less than 1% and is a deleterious, protein altering variant with a strong effect that increases or decreases (LILRB1.pY331X) risk of AD. Additional variants in these genes also alter risk of AD. The variants identified here are ideally suited for studies aimed at understanding how the innate immune system may be modulated to alter risk of AD.
Motorcycle Accidents are the Strongest Risk Factor for Panfacial Fractures Among Pediatric Patients
Stanbouly, Dani , Koh, Dylan, Goudarzi, Fereshteh , Arce, Kevin , Chuang, Sung‐Kiang, Halsey, Jordan N. , Selvi, Fırat

Mayo Clinic

Craniomaxillofacial Trauma & Reconstruction | August 3, 2022 | Volume: 16 | Issue: 4 | Pages: 258-267

10.1177/19433875221116961 | PMID 38047150 Get It

Study Design A retrospective cohort study was conducted using the Kids’ Inpatient Database from 2000 to 2014. Subjects were included if they were 18 years and younger and suffered any type of facial fracture. Objective The purpose this study was to determine the risk factors for incurring panfacial fractures among the pediatric population. Methods The primary predictor variables were a set of heterogenous variables that included patient characteristics, injury characteristics, hospitalization outcomes. The primary outcome variable was panfacial fracture. Logistic regression was used to determine the independent risk factors for panfacial fractures. Results Relative to infants and toddlers, teenagers were nearly three times more likely to sustain panfacial fractures ( P < .01). Relative to no chronic conditions, patients with one or more chronic conditions were more likely to incur panfacial fractures. Motorcycle accidents were over three times more likely ( P < .01) to result in panfacial fractures while car accidents were over two times more likely ( P < .01) to result in panfacial fractures. Falls were less likely (OR, .39; P < .01) to result in panfacial fractures. Conclusions Motor vehicle accidents was a major risk factor for panfacial fractures. Teenagers are also found to have an increased risk for panfacial fractures relative to infants and toddlers. Each additional chronic condition was a significant risk factor for suffering panfacial fractures relative to not having any chronic condition at all. In contrast, falls independently decreased the risk of incurring a panfacial fractures. Special attention should be given to safety precautions when occupying a motor vehicle.
Analysis of Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2014-2021
Shir, Dror , Lazar, Evelyn, Graff‐Radford, Jonathan , Aksamit, Allen J. , Cutsforth‐Gregory, Jeremy K. , Prusinski, Christian , Porter, Amanda , Day, Gregory S. , Lazar, Evelyn B, Day, Gregory S , Shir, Dror , Jones, David T. , Botha, Hugo , Ramanan, Vijay K.

Mayo Clinic

JAMA Network Open | August 3, 2022 | Volume: 5 | Issue: 8 | Pages: e2225098

10.1001/jamanetworkopen.2022.25098 | PMID 35921110 Get It

Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey
Yoshida, Akira , Kim, Minchul , Kuwana, Masataka , Ravichandran, Naveen , Makol, Ashima , Sen, Parikshit , Agarwal, Vishwesh , Kardeş, Sinan , Day, Jessica , Milchert, Marcin , Joshi, Mrudula , Salim, Babur , Velikova, Tsvetelina , Gracia‐Ramos, Abraham Edgar , Parodis, Ioannis , Selva-O’Callaghan, Albert , Nikiphorou, Elena , Chatterjee, Tulika , Tan, Ai Lyn , Nune, Arvind , Ziadé, Nelly , Chinoy, Hector , Agarwal, Vikas , Gupta, Latika, Group, COVAD Study, Singh, Yogesh Preet , Jain, Avinash , Pandya, Sapan C , Sharma, Aman , Manesh, Manoj M, Patro, Pradeepta Sekhar , Ajmani, Sajal , Chowdhury, Abhra Chandra , Shenoy, Padnamabha, Asranna, Ajay, Bommakanti, Keerthi Talari, Shukla, Anuj , Pandey, Arun Kumar R, Pauling, John D , Sambataro, Gianluca , Atzeni, Fabiola , Govoni, Marcello, Bocci, Elena Bartoloni, Orsolini, Giovanni , Danielli, Maria Giovanna, Tehozol, Erick Adrian Zamora , Loarce‐Martos, Jesus , Prieto‐González, Sergio , Nakashima, Ran , Sato, Shinji, Kaneko, Yuko , Tomaras, Stylianos , Aharonov, Or, Maurier, F. , Meyer, Alain, Nagy‐Vincze, Melinda , Limaye, Vidya , Needham, Merrilee , Srivastav, Nilesh , Hudson, Marie , Landon‐Cardinal, Océane , Shaharir, Syahrul Sazliyana , Zuleta, Wilmer Gerardo Rojas, Silva, José António Pereira, Gupta, Latika , Lilleker, James B , Day, Jessica , Gracia-Ramos, Abraham Edgar , Parodis, Ioannis , Selva O'Callaghan, Albert , Tan, Ai Lyn , Nune, Arvind , Ziade, Nelly , Knitza, Johannes , Distler, Oliver , Chinoy, Hector , Gupta, Latika , Milchert, Marcin , Agarwal, Vikas , Joshi, Mrudula , Agarwal, Vishwesh , Kim, Minchul , Makol, Ashima , Velikova, Tsvetelina , Chatterjee, Tulika , Pauling, John D , Naveen, R , Zamora Tehozol, Erick Adrian , Sen, Parikshit , Yoshida, Akira , Singh, Yogesh Preet , Gheita, Tamer A. , Cavagna, Lorenzo , Saavedra, Miguel A , Shinjo, Samuel Katsuyuki , Distler, Oliver , Aggarwal, Rohit , Group, COVAD Study, Barman, Bhupen , Ranjan, Rajiv , Pilania, Rakesh Kumar , Gupta, Vikas , Kavadichanda, Chengappa G. , Phatak, Sanat B. , Goswami, Rudra P , Mathew, Ashish Jacob , Chandwar, Kunal , Cansu, Döndü Üsküdar , Wincup, Chris , Papa, Nicoletta Del , Parisi, Simone , Bocci, Elena Bartoloni, Sebastiani, Gian Domenico , Fusaro, Enrico , Sebastiani, Marco , Quartuccio, Luca , Franceschini, Franco , Sainaghi, Pier Paolo , Angelis, Rossella De , Venerito, Vincenzo , Traboco, Lisa S , Wibowo, Suryo Anggoro Kusumo , Rojas Serrano, Jorge , Torre, Ignacio García‐De La , Gil‐Vila, Albert , Gonzalez, Raquel Aranega, Kimura, Naoki, Gromova, Margarita Aleksandrovna , Hmamouchi, Ihsane , Hoff, Leonardo Santos , Giannini, Margherita , Campagne, Julien , Meyer, Alain , Langguth, Daman , Silva, José António Pereira, Fonseca, João Eurico , Zimba, Olena

Mayo Clinic

Rheumatology | August 3, 2022 | Volume: 62 | Issue: 3 | Pages: 1204-1215

10.1093/rheumatology/keac441 | PMID 35920795 Get It

AbstractObjectivesThe assessment of physical function is fundamental in the management of patients with idiopathic inflammatory myopathies (IIMs). We aimed to investigate the physical function of patients with IIMs compared with those with non-IIM autoimmune rheumatic diseases (AIRDs) utilizing Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function (PF) data obtained in the COVAD study, an international self-reported e-survey assessing the safety of COVID-19 vaccines in AIRDs.MethodsDemographics, AIRD diagnosis, disease activity, and PROMIS PF short form-10a data were extracted from the COVAD database. PROMIS PF-10a scores were compared between disease categories and stratified by disease activity. Factors affecting PROMIS PF-10a scores other than disease activity were identified by multivariable regression analysis in patients with inactive disease.ResultsA total of 1057 IIM patients, 3635 non-IIM AIRD patients and 3981 healthy controls (HCs) responded to the COVAD e-survey from April to August 2021. Using a binomial regression model, the predicted mean of PROMIS PF-10a scores was significantly lower in IIM patients compared with non-IIM AIRD patients or HCs [36.3 (95% CI 35.5, 37.1) vs 41.3 (95% CI 40.2, 42.5) vs 46.2 (95% CI 45.8, 46.6), P &lt; 0.001], irrespective of disease activity. The independent factors for lower PROMIS PF-10a scores in patients with inactive disease were older age, female, longer disease duration, and a diagnosis of inclusion body myositis or polymyositis.ConclusionPhysical function is significantly impaired in IIMs compared with non-IIM AIRDs or HCs, even in patients with inactive disease. Our study highlights a critical need for better strategies to minimize functional disability in patients with IIMs.
Knowledge, attitudes, and beliefs of oncology trainees on function and cancer rehabilitation medicine
Molinares, Diana , Parke, Sara C. , Yadav, Rajesh , Liu, Diane , Williams, Janet L. , Parke, Sara, Parke, Sara C , Bruera, Eduardo

Mayo Clinic

PM&R | August 3, 2022 | Volume: 15 | Issue: 8 | Pages: 982-989

10.1002/pmrj.12881 | PMID 36762725 Get It

AbstractBackgroundImproved function is associated with reduced morbidity and mortality in patients with cancer. Cancer rehabilitation medicine (CRM) is a subspecialty of physical medicine and rehabilitation (PM&R) that focuses on improving function in patients with cancer. One of the barriers to patients accessing CRM services is the lack of referrals from oncology providers. Understanding the knowledge, attitudes and beliefs of oncology trainees regarding the importance of function and the role of CRM is essential to reducing educational gaps and improving patients' access to essential rehabilitation services.ObjectiveTo determine oncology trainees' knowledge, attitude and beliefs about the importance of function and the role of CRM in the care of patients with cancer.SettingThe study was conducted at a comprehensive cancer center in the United States.InterventionDescriptive survey study was administered to postgraduate oncology trainees who spent at least 1 day a week providing patient care.Main outcomeParticipants' report of their knowledge, attitudes, and beliefs on the importance of function and CRM in the care of patients with cancer.ResultsThe survey was sent to 197 oncology trainees with a response rate of 67% (n = 132) and 126 were ultimately included. All participants believed that function is important in the care of patients with cancer. The majority believed that better function improves treatment tolerance (94%) and survival (84%). Most reported that having CRM physicians (80%) and an inpatient rehabilitation unit (88%) in the oncological setting is important; however, most participants reported that they refer fewer than 25% of their patients to CRM services. Participants with prior exposure to PM&R were significantly more likely to consult PM&R compared to those without exposure (p = .005). Most oncology trainees (81%) believed that education in CRM should be part of their oncology training.ConclusionThis study demonstrates that oncology trainees believe that function is important. They also believe that access to CRM would improve treatment tolerance and survival, but most report that they rarely refer patients to CRM services. Most trainees desire increased exposure to CRM during oncology training.
Pulmonary Vascular Research Institute GoDeep: A meta‐registry merging deep phenotyping datafrom international PH reference centers
Majeed, Raphael W. , Anthi, Anastasia , Cannon, John, Chan, Stephen Y. , Damonte, Victoria , Elwing, Jean , Förster, Kai , Ghouleh, Imad Al , Juaneda, Ernesto , Kiely, David G. , Orfanos, Stylianos E. , Pepe, Antonella, Sіrenko, Yu.M. , Swett, Andrew J., Zamanian, Roham T. , Marquardt, Kurt , Michel‐Backofen, Achim, Antoine, Tobiah, Wilhelm, Jochen , Barwick, Stephanie , Krieb, Phillipp, Fuenderich, Meike, Ghofrani, Hossein‐Ardeschir, Tello, Khodr , Richter, Manuel J. , Seeger, Werner , Sweatt, Andrew J. , Chan, Stephen Y , Frantz, Robert P , Jose, Arun , Lawrie, Allan , Gall, Henning , Seeger, Werner , Kiely, David , Majeed, Raphael W , Wilkins, Martin R. , Howard, Luke , Hassoun, Paul M. , Cajigas, Héctor , Frantz, Robert P. , Ghio, Stefano , Hilgendorff, Anne , Jose, Arun , Pepe, Antonella, Pepke‐Żaba, Joanna , Torbas, O.O. , Michel-Backofen, Achim, Barwick, Stephanie, Fünderich, Meike , Fischer, Patrick, Gall, Henning , Ghofrani, Hossein‐Ardeschir, Grimminger, Friedrich

Mayo Clinic

Pulmonary Circulation | August 3, 2022 | Volume: 12 | Issue: 3 | Pages: No page available

10.1002/pul2.12123 | PMID 36034404 Get It

AbstractThe Pulmonary Vascular Research Institute GoDeep meta‐registry is a collaboration of pulmonary hypertension (PH) reference centers across the globe. Merging worldwide PH data in a central meta‐registry to allow advanced analysis of the heterogeneity of PH and its groups/subgroups on a worldwide geographical, ethnical, and etiological landscape (ClinTrial. gov NCT05329714). Retrospective and prospective PH patient data (diagnosis based on catheterization; individuals with exclusion of PH are included as a comparator group) are mapped to a common clinical parameter set of more than 350 items, anonymized and electronically exported to a central server. Use and access is decided by the GoDeep steering board, where each center has one vote. As of April 2022, GoDeep comprised 15,742 individuals with 1.9 million data points from eight PH centers. Geographic distribution comprises 3990 enrollees (25%) from America and 11,752 (75%) from Europe. Eighty‐nine perecent were diagnosed with PH and 11% were classified as not PH and provided a comparator group. The retrospective observation period is an average of 3.5 years (standard error of the mean 0.04), with 1159 PH patients followed for over 10 years. Pulmonary arterial hypertension represents the largest PH group (42.6%), followed by Group 2 (21.7%), Group 3 (17.3%), Group 4 (15.2%), and Group 5 (3.3%). The age distribution spans several decades, with patients 60 years or older comprising 60%. The majority of patients met an intermediate risk profile upon diagnosis. Data entry from a further six centers is ongoing, and negotiations with >10 centers worldwide have commenced. Using electronic interface‐based automated retrospective and prospective data transfer, GoDeep aims to provide in‐depth epidemiological and etiological understanding of PH and its various groups/subgroups on a global scale, offering insights for improved management.
Prognostic Implications of a Morphometric Evaluation for Chronic Changes on All Diagnostic Native Kidney Biopsies
Đenić, Aleksandar , Bogojevic, Marija , Sabov, Moldovan, Asghar, Muhammad Sohaib , Sethi, Sanjeev , Fervenza, Fernando C. , Glassock, Richard J. , Asghar, Muhammad S , Rule, Andrew D , Fervenza, Fernando C , Denic, Aleksandar , Mullan, Aidan F. , Smith, Maxwell L. , Hommos, Musab S. , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | August 3, 2022 | Volume: 33 | Issue: 10 | Pages: 1927-1941

10.1681/asn.2022030234 | PMID 35922132 Get It

Background Semiquantitative visual inspection for glomerulosclerosis, interstitial fibrosis, and arteriosclerosis is often used to assess chronic changes in native kidney biopsies. Morphometric evaluation of these and other chronic changes may improve the prognostic assessment. Methods We studied a historical cohort of patients who underwent a native kidney biopsy between 1993 and 2015 and were followed through 2021 for ESKD and for progressive CKD (defined as experiencing 50% eGFR decline, temporary dialysis, or ESKD). Pathologist scores for the percentages of globally sclerosed glomeruli (GSG), interstitial fibrosis and tubular atrophy (IFTA), and arteriosclerosis (luminal stenosis) were available. We scanned biopsy sections into high-resolution images to trace microstructures. Morphometry measures were percentage of GSG; percentage of glomerulosclerosis (percentage of GSG, ischemic-appearing glomeruli, or segmentally sclerosed glomeruli); percentage of IFTA; IFTA foci density; percentage of artery luminal stenosis; arteriolar hyalinosis counts; and measures of nephron size. Models assessed risk of ESKD or progressive CKD with biopsy measures adjusted for age, hypertension, diabetes, body mass index, eGFR, and proteinuria. Results Of 353 patients (followed for a median 7.5 years), 75 developed ESKD and 139 experienced progressive CKD events. Visually estimated scores by pathologists versus morphometry measures for percentages of GSG, IFTA, and luminal stenosis did not substantively differ in predicting outcomes. However, adding percentage of glomerulosclerosis, IFTA foci density, and arteriolar hyalinosis improved outcome prediction. A 10-point score using percentage of glomerulosclerosis, percentage of IFTA, IFTA foci density, and any arteriolar hyalinosis outperformed a 10-point score based on percentages of GSG, IFTA, and luminal stenosis >50% in discriminating risk of ESKD or progressive CKD. Conclusion Morphometric characterization of glomerulosclerosis, IFTA, and arteriolar hyalinosis on kidney biopsy improves prediction of long-term kidney outcomes.
Tcf-1 promotes genomic instability and T cell transformation in response to aberrant β-catenin activation
Arnovitz, Stephen , Mathur, Priya , Tracy, Melissa, Mohsin, Azam , Mondal, Soumi , Quandt, Jasmin , Hernandez, Kyle M. , Khazaie, Khashayarsha , Dose, Marei , Emmanuel, Akinola Olumide , Gounari, Fotini , Gounari, Fotini

Mayo Clinic

Proceedings of the National Academy of Sciences | August 3, 2022 | Volume: 119 | Issue: 32 | Pages: No page available

10.1073/pnas.2201493119 | PMID 35921443 Get It

Understanding the mechanisms promoting chromosomal translocations of the rearranging receptor loci in leukemia and lymphoma remains incomplete. Here we show that leukemias induced by aberrant activation of β-catenin in thymocytes, which bear recurrent Tcra/Myc-Pvt1 translocations, depend on Tcf-1. The DNA double strand breaks (DSBs) in the Tcra site of the translocation are Rag-generated, whereas the Myc-Pvt1 DSBs are not. Aberrantly activated β-catenin redirects Tcf-1 binding to novel DNA sites to alter chromatin accessibility and down-regulate genome-stability pathways. Impaired homologous recombination (HR) DNA repair and replication checkpoints lead to retention of DSBs that promote translocations and transformation of double-positive (DP) thymocytes. The resulting lymphomas, which resemble human T cell acute lymphoblastic leukemia (T-ALL), are sensitive to PARP inhibitors (PARPis). Our findings indicate that aberrant β-catenin signaling contributes to translocations in thymocytes by guiding Tcf-1 to promote the generation and retention of replication-induced DSBs allowing their coexistence with Rag-generated DSBs. Thus, PARPis could offer therapeutic options in hematologic malignancies with active Wnt/β-catenin signaling.
Who Will Get Paid for Artificial Intelligence in Medicine?
Rowell, Colin , Sebro, Ronnie

Mayo Clinic

Radiology: Artificial Intelligence | August 3, 2022 | Volume: 4 | Issue: 5 | Pages: No page available

10.1148/ryai.220054 | PMID 36204537 Get It

A Bayesian model for combining standardized mean differences and odds ratios in the same meta-analysis
Jing, Yaqi , Murad, M. Hassan , Lin, Lifeng , Murad, M Hassan , Lin, Lifeng , Jing, Yaqi

Mayo Clinic

Journal of Biopharmaceutical Statistics | August 3, 2022 | Volume: 33 | Issue: 2 | Pages: 167-190

10.1080/10543406.2022.2105345 | PMID 35920674 Get It